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Two new thermophilic branched chain amino acid transaminases have been identified
within the genomes of different hyper-thermophilic archaea, Geoglobus acetivorans, and
Archaeoglobus fulgidus. These enzymes belong to the class IV of transaminases as
defined by their structural fold. The enzymes have been cloned and over-expressed
in Escherichia coli and the recombinant enzymes have been characterized both
biochemically and structurally. Both enzymes showed high thermostability with optimal
temperature for activity at 80 and 85◦C, respectively. They retain good activity
after exposure to 50% of the organic solvents, ethanol, methanol, DMSO and
acetonitrile. The enzymes show a low activity to (R)-methylbenzylamine but no activity to
(S)-methylbenzylamine. Both enzymes have been crystallized and their structures solved
in the internal aldimine form, to 1.9 Å resolution for the Geoglobus enzyme and 2.0 Å for
the Archaeoglobus enzyme. Also the Geoglobus enzyme structure has been determined
in complex with the amino acceptor α-ketoglutarate and the Archaeoglobus enzyme in
complex with the inhibitor gabaculine. These two complexes have helped to determine
the conformation of the enzymes during enzymatic turnover and have increased
understanding of their substrate specificity. A comparison has been made with another
(R) selective class IV transaminase from the fungus Nectria haematococca which was
previously studied in complex with gabaculine. The subtle structural differences between
these enzymes has provided insight regarding their different substrate specificities.
Keywords: thermophilic archaea, branched-chain aminotransferases, substrate specificity, X-ray structural
analysis, biocatalysis
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INTRODUCTION
Transaminases (TAms; aminotransferases; EC2.6.1.-) catalyse a
transfer of an amino group between a donor substrate and an
acceptor molecule (Mehta et al., 1993). They are involved in
the metabolism of most natural amino acids and collectively
have a broad substrate range. This makes them very useful
for the biocatalytic synthesis of chiral amino acid analogs
(Leuchtenberger et al., 2005; Tufvesson et al., 2011) such as tert-
leucine (Taylor et al., 1998) and homophenylalanine (Cho et al.,
2003).
The TAms belong to a large group of enzymes that utilize
pyridoxal 5′-phosphate (PLP) (Hayashi, 1995; Jansonius, 1998).
PLP is the biologically active form of vitamin B6 (Braunstein
and Shemyakin, 1953; Metzler et al., 1954). The mechanism of
these enzymes involves the PLP cofactor forming a covalent
bond (a Schiff base) with the NZ atom of the active-site lysine
(internal aldimine). In the first half of the TAm reaction, a Schiff
base is formed between the donor substrate and PLP (external
aldimine). After several reaction stages, the substrate amino
group is transferred to the cofactor to form pyridoxamine 5′-
phosphate (PMP) with the release of the ketone product. In the
second half-reaction the PMP amino group is transferred to an
acceptor ketone or aldehyde to form the PLP internal aldimine
and a primary amine or a chiral amino product. Most TAms use
an α-ketoglutarate (AKG) acceptor substrate to form a glutamate
product. Some TAms, however utilize the pyruvate acceptor to
form alanine and are usually referred to as substrate:pyruvate
TAms (Ward and Wohlgemuth, 2010; Sayer et al., 2012).
The TAms are currently widely used in industrial biocatalysis
for both the resolution and the asymmetric synthesis of chiral
amines which are used as building blocks for drug intermediates.
There is specific interest in TAms capable of the production
of both (S) and (R)-chiral intermediates of non α-amino acid
substrates. These enzymes catalyse amination of substrates with
a ketone/aldehyde component distal to the carboxyl group
[ω-TAms; (Malik et al., 2012)] or with no carboxyl group
[amine TAms; (Shin et al., 2003)]. Several Pfam class III (S)-
selective ωTAms (Punta et al., 2012) from Vibrio fluvialis (Shin
et al., 2003), Chromobacterium violaceum and Pseudomonas
aeruginosa (Kaulmann et al., 2007), Arthrobacter sp. and Bacillus
megaterium (van Oosterwijk et al., 2016) have been biochemically
and structurally characterized (Humble et al., 2012; Midelfort
et al., 2013; Sayer et al., 2013). They show activity toward the
(S)-isoform of α-methylbenzylamine [(S)-MBA] and also toward
other amines and ω-amino acids such as β-alanine. The amino
acceptor can be pyruvate and a variety of other ketones and
aldehydes (Kaulmann et al., 2007).
Most α-TAms and (S)-ωTAms, are specific toward the (S)-
enantiomer of the substrate and have a PLP type I fold. Enzymes
of the Pfam TAm class IV have a PLP type IV fold and catalyse
transamination of branched chain L-amino acids (BCAAs), D-
amino acids or ω-amino acids. The catalysis in class IV TAms
occurs on the re-side of the cofactor, which differs from most
of the other PLP enzymes where the reactions occur on the si-
side. Since both (S) and (R)-enantiomers can be turned over
within the same PLP type IV scaffold, enzymes capable of
transamination of (R)-ω-substituted amines are found within
this class of TAms. By comparing the sequence for class IV
enzymes which are potentially capable of (R)-ωTAm activity a
sequence fingerprint has been established (Höhne et al., 2010).
Biochemical characterization of a number of these enzymes has
demonstrated a high enantioselectivity toward the substrates (R)-
α-methylbenzylamine [(R)-MBA], (2R)-amino-4-phenylbutane
and (2R)-aminohexane.
The production of the (R)-ω-substituted chiral amines is a
challenging process using conventional chemical synthesis.
Therefore, enzymes capable of catalyzing the selective
transamination of such compounds have received significant
interest. An example of such an enzyme is a mutant (R)-specific
transaminase from Arthrobacter sp. (ArRMut11), created in
a collaboration between Codexis and Merck, which was able
to catalyse specific amination of the sterically demanding 1,3-
ketoamides to generate the (R)-chiral amine for the manufacture
of Sitagliptin, a treatment for type II diabetes (Savile et al., 2010).
This mutant ArRMut11 enzyme has been reported in reactions
for amination of bicyclic ketones including tetralone (Mutti
et al., 2011; Pressnitz et al., 2013). The crystal structures have
been reported for several class IV TAm enzymes including the
fungal (R)-amine:pyruvate ωTAms from Aspergillus fumigatus
(Thomsen et al., 2014), Aspergillus terreus (Łyskowski et al.,
2014) and Nectria haematococca (Sayer et al., 2014), and the
bacterial (R)-selective ωTAm ArRMut11 from Arthrobacter sp
(Guan et al., 2015).
There is an increasing demand for enzymes which are more
robust to the demanding conditions used in industry. Enzymes
found in thermophilic organisms have increased thermostability
and are more tolerant to organic solvents and proteolytic
cleavage. Solvent stability is advantageous since non-natural
substrates used industrially often require the addition of organic
solvents to the reaction mixture for substrate solubilisation
(Littlechild et al., 2007). Also the biocatalytic process can be
carried out at elevated temperatures where many non-natural
substrates have improved solubility when using a thermostable
enzyme which can be reused through several reaction cycles. This
reduces the overall cost of the enzyme in the industrial process
which is often a limitation in the development of a biocatalytic
process.
Branched chain TAms (BCATs) catalyse reversible
transamination of branched chain amino acids (shown in
Scheme 1). Recently, archaeal thermophilic BCATs have been
biochemically characterized from Thermococcus sp (Uchida
et al., 2014) and biochemically and structurally studied from the
thermophile Thermoproteus uzoniensis (Boyko et al., 2016).
This paper reports the identification, biochemical and
structural characterization of two new thermostable archaeal
class IV TAms fromGeoglobus acetivorans (Querellou et al., 2009)
and Archaeoglobus fulgidus (Stetter, 1988). Both of these hyper-
thermophilic archaea have been isolated from different deep sea
hydrothermal vents and they share 79.2% sequence identity. The
structures of the G. acetivorans enzyme have been determined
in the internal aldimine form and in complex with the amino
acceptor AKG and the structures of the A. fulgidus enzyme in
the internal aldimine form and in complex with the inhibitor
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SCHEME 1 | Reaction of Branched Chain TAms.
gabaculine. The different structural complexes of these related
enzymes have given further insight into the overall mechanism
of BCATs and their high stability for industrial application and
their substrate specificity.
RESULTS AND DISCUSSION
Enzyme Cloning, Expression, and
Purification
The genes encoding two putative BCATs were identified in
the genomes of G. acetivorans (Mardanov et al., 2011) and A.
fulgidus (Klenk et al., 1997). Both proteins called GEO1900
and AF0933 have been cloned and over-expressed in a soluble
form in Escherichia coli and have been purified to homogeneity
using metal affinity and size exclusion chromatography. The
recombinant BCATs GEO1900 (MW of subunit 32.6 kDa, 292
amino acids) and AF0933 (MW of subunit 32.4 kDa, 290 amino
acids) are closely related with a sequence identity of 79.2% and
94.8% similarity. When purified by high resolution gel filtration
chromatography the native molecular weight of the two enzymes
varied with the GEO1900 approximately 70 kDa, indicating that
the enzyme was a homodimer with small amount of tetramer
in solution (Figure S1). However, the AF0933 enzyme had a
native molecular mass of approximately 220 kDa as determined
by size exclusion chromatography, indicating that it forms a
homo-hexamer with only small amounts of a homo-dimeric
enzyme observed (Figure S2). Both proteins showed absorption
at 420 nm indicating that the cofactor PLP was bound in the
aldimine form (data not shown). Both of the GEO1900 and
AF0933 proteins run as a single band of 36 kDa on SDS-PAGE
which is in line with the calculated molecular mass of the His-
tagged proteins (35.4 kDa).
Biochemical Characterization of GEO1900
and AF0933
Both enzymes, GEO1900 and AF0933, showed significant activity
toward keto analogs of BCAAs (Tables 1, 2). The apparent
kinetic parameters for the AF0933 catalyzed transamination
reaction between L-glutamate and the branched chain oxoacids
were similar with a preference for 3-methyl-2-oxopentanoate.
The extrapolated Vmax and Km values for L-glutamate were
significantly higher (Table 2 and Figure S7). These values of
Vmax and Km point to the low affinity binding of L-Glu in the
active site. This was observed earlier for other BCATs from P.
FIGURE 1 | Electron density for the bound substrate AKG in the active site of
subunit A of the GEO1900. The 2Fo-Fc electron density map (blue) is
contoured at 1.5σ, the positive (green) and negative (red) Fo-Fc electron
density maps are contoured at 3.5σ and −3.5σ, respectively. Figure drawn
using PyMOL (Schrödinger, LLC).
aeruginosa and Gluconobacter oxydans (Norton and Sokatch,
1970; Tachiki and Tochikura, 1973; Kanda et al., 1995). For
GEO1900 the extrapolated Vmax and Km values for pyruvate and
AKG were (1.9 ± 0.1 U/mg and 10.6 ± 1.9mM) and (18.2 ±1.2
U/mg and 1.9 ± 0.6mM), respectively. The calculated catalytic
efficiency constant for GEO1900 toward AKG was found to be
higher than toward pyruvate, 9.8 s−1 mM−1 compared to 0.1 s−1
mM−1. Both values fall within the range of the calculated values
for the canonical BCATs (Bezsudnova et al., 2017).
As for the activity toward amino donors the profile of activity
toward amino acids for GEO1900 (Table S1) was similar to
that reported for related BCATs from E.coli, Bacillus brevis
and Pseudomonas aeruginosa (Norton and Sokatch, 1970; Lee-
Peng et al., 1979; Inoue et al., 1988; Kanda et al., 1995; Yu
et al., 2014). GEO1900 was highly active toward branched-
chain amino acids and their isomers. The AF0933 catalyzed
the transamination between L-valine and AKG with a specific
activity of 5.76 U/mg and between L-alanine and 3-methyl-2-
oxobutanoic acid with a lower specific activity of 0.16 U/mg.
When the enantio-preference of the GEO1900 and AF0933 in
the reaction with the (R) and (S)-isomers of methylbenzylamine
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TABLE 1 | The specific activity of GEO1900 and AF0933 toward different keto
acids.
Amino acceptor Specific activity (U/mg)
GEO1900a AF0933b
3-methyl-2-oxobutyrate n.a. 5.14
4-methyl-2-oxopentanoate 7.7 3.05
3-methyl-2-oxopentanoate 7.1 3.23
2-oxopentanoate n.a. 6.51
2-oxohexanoate n.a. 4.26
2-oxooctanoate n.a. 2.4
2-oxobutyrate 1.3 n.a.
pyruvate 0.56 0.73
phenylglyoxylate n.a. 4.55
β-phenylpyruvate n.a. 2.84
indole-3-pyruvate n.a. 1.02
a5mM L-glutamate was used as the amino donor and 5mM keto acid was used at 65◦C
in 50mM phosphate buffer, pH 8.0; supplemented with 60µM PLP.
b10mM L-glutamate was used as the amino donor and 10mM keto acid was used at
70◦C in 100mM Tris-HCl buffer pH 7.5 supplemented with 0.1mM PLP.
Not all donor acceptor pairs were tested for both enzymes.
TABLE 2 | The apparent kinetic parameters of the transamination reaction
catalyzed by AF0933.
Substrate Vmax (U/mg) Km (mM) kcat/Km (s−1 mM−1)
3-methyl-2-oxobutyratea 6.3 0.42 8.85
4-methyl-2-oxopentanoatea 5.5 0.25 12.98
3-methyl-2-oxopentanoatea 3.9 0.13 17.7
L-glutamateb 64.6* 121 0.32
aAt 10mM L-glutamate.
bAt 5mM 3-methyl-2-oxobutyrate.
*The Vmax for L-glutamate is an extrapolated value calculated at saturated concentration
of co-substrate.
(MBA) was investigated using the acetophenone assay they both
showed a small but significant activity toward (R)-MBA at pH 7.5,
with a value of 2 and 10 mU/mg with 2-oxobutyrate as the keto
substrate, respectively. Neither BCAT showed any activity toward
(S)-MBA.
The temperature optimum for the transamination reaction
catalyzed by GEO1900 and AF0933 was found to be 80
and 85◦C, respectively (Figures S3, S5). The pH optimum
for amination of keto acids with L-Glu was between pH 7.0
and 8.0 for both enzymes. The thermostability of GEO1900
and AF0933 was evaluated using the analysis of the residual
activity after pre-incubation of the enzyme for 2 h at different
temperatures. Significant loss of activity of GEO1900 was
observed at temperatures higher than 50◦C. The pre-incubation
of the enzyme at 70◦C resulted in 25% loss of activity after 2 h
(Figure S4). At the same time more than 60% of the AF0933
residual activity remained after pre-incubation at 75◦C for 2 h
(Figure S6). The pre-incubation of AF0933 at 85◦C for 60min
resulted in a drop of the residual activity to 30%.
The solvent stability of GEO1900 and AF0933 was tested
in ethanol, methanol, DMSO and acetonitrile. After 1 h of
incubation in up to 50% of these solvents GEO1900 retained close
to 100% activity at both 20◦C and 55◦C. For AF0933 after 1 h
incubation of the enzyme in up to 50% of the tested solvents at
the similar temperatures 80% of the original activity remained.
Structural Studies
The GEO1900 holoform (internal aldimine form;
GEO1900_holo) and the unproductive complex of holoenzyme
with the keto substrate AKG-(GEO1900_AKG) have been
determined to 1.9 and 2.2 Å resolution, respectively, in the
trigonal space group P3221. There are three GEO1900 subunits
per asymmetric unit, which form a tight hexamer with 32
point group symmetry with their symmetry mates. The AF0933
structure has been determined in the holoform (AF0933_holo)
and in complex with the inhibitor gabaculine (GABC)
(AF0933_GABC) to 2.1 and 2.0 Å resolution, respectively,
in the orthorhombic P212121 space group. The asymmetric unit
contains a hexameric AF0933 molecule which is very similar to
GEO1900 hexamer observed in the crystal. All of the structures
have been refined to low R-factors with good stereochemical
parameters as shown in Table 3. In the GEO1900 structures
two N-terminal amino acids which are not present in AF0933,
were not defined in the electron density. The interdomain
loop residues 121–129 could be fully built into the subunits A
and B in GEO1900_AKG structure. The bound ligand AKG
was found only in subunit A and was clearly defined in the
electron density (Figure 1). The interdomain loop could only
be fully built in one subunit (D) out of the six subunits in
both the AF0933_holo and AF0933_GABC structures. The
crystal contacts in AF0933 appear to be contributing to the
lower disorder of the loop in the D subunit. The inhibitor,
gabaculine was not present in the electron density in the subunit
F of AF0933, therefore this subunit was built as an internal
aldimine in the AF0933_GABC structure. In other subunits the
gabaculine-PLP adduct was modeled with partial occupancy in
the range of 0.6–0.7. There are no residues in a cis conformation
in the well-defined regions of the GEO1900 and AF0933
structures. Residue Glu249 is a Ramachandran plot outlier
(Ramakrishnan and Ramachandran, 1965) in all subunits of both
AF0933 structures. The corresponding Glu251 has similar main
chain angles in the GEO1900 structures, but lies in a generously
allowed region of the Ramachandran plot (Laskowski et al.,
1993). The fungal class IV TAms from Aspergillus and Nectria
species (Łyskowski et al., 2014; Sayer et al., 2014; Thomsen
et al., 2014) have a Gly residue at this position. Many residues
in both of the GEO1900 and AF0933 structures have been
modeled with multiple conformations of some amino acid side
chains. The residues Gln107 and Asn108 were modeled with
alternative conformations of the main chain in most subunits of
the AF0933_holo structure and in the subunits E and F of the
AF0933_GABC structure.
Subunit Structure
The subunit of the archaeal BCATs has a PLP type IV fold typical
of other BCATs, D-amino acid TAms and (R)-selective ωTAms
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TABLE 3 | Summary of data processing and refinement statistics.
Holo enzyme
GEO1900
α-ketoglutarate
complex GEO1900
Holo enzyme
AF0933
Gabaculine
complex AF0933
Diffraction source BL41XU, Spring8 BL41XU, Spring8 I04-1, Diamond I04-1, Diamond
Wavelength (Å) 1.0 1.0 0.92 0.92
Space group P3221 P3221 P212121 P212121
a, b, c (Å) 117.65, 117.65,
135.98
117.31, 117.31, 135.31 72.92, 139.12,
167.57
73.21, 140.23,
168.32
α, β, γ (◦) 90, 90, 120 90, 90, 120 90, 90, 90 90, 90, 90
Resolution range (Å) 58.83–1.90
(2.00–1.90)a
67.66–2.20 (2.26–2.20) 69.60–2.10
(2.14–2.10)
67.17–1.98
(2.01–1.98)
Number of unique reflections 85638 (11949) 55018 (4457) 99985 (4906) 119864 (5675)
Completeness (%) 99.6 (98.6) 99.9 (99.8) 99.9 (99.6) 99.0 (95.6)
Average redundancy 19.8 (19.3) 17.7 (18.4) 6.3 (5.4) 5.6 (4.7)
<I/σ(I)> 31.75 (4.0) 15.1 (4.9) 10.0 (0.8) 11.2 (0.8)
Rmeas (%)b 6.8 (79.2) 13.3 (67.4) 14.7 (251.1) 12.8 (233.5)
CC1/2 (%; Diederichs and Karplus, 1997) 100 (92.9) 99.8 (92.6) 99.7 (29.2) 99.7 (24.9)
Overall B factor from Wilson plot (Å2)c 39.8 42.3 51.3 44.8
Rfact (%) 15.3 15.0 18.3 18.1
Rfree (%) 18.8 20.8 21.8 20.9
Refined protein atoms 6671 6836 14432 14440
Refined solvent atoms 626 508 754 828
Refined ligand atoms 0 10 0 125
AVERAGE B FACTOR (Å2)
Protein 37.9 38.2 45.8 42.7
Solvent 45.3 40.9 50.6 47.9
R.m.s.d. bond lengths (Å) 0.021 0.019 0.013 0.013
R.m.s.d. bond angles (◦) 1.99 2.11 1.78 1.69
RAMACHANDRAN PLOT ANALYSIS, RESIDUES IN (%)d
Most favored regions 90.5 89.9 90.6 90.7
Additional allowed regions 8.7 8.8 8.6 8.5
Generously allowed regions 0.8 1.1 0.4 0.4
Disallowed regions 0 0.3 0.4 0.4
aValues for the highest resolution shell are given in parentheses.
bRmeas = Σh [m/(m – 1)]
1/2 Σ i |Ih,i | – <Ih >/ Σh Σi Ih,i (Karplus and Diederichs, 2012).
cWilson B-factor was estimated by SFCHECK (Vaguine et al., 1999).
dRamachandran plot analysis was performed by PROCHECK (Laskowski et al., 1993).
(Mehta et al., 1993; Höhne et al., 2010) and consists of two
α/β domains, a small domain and a large domain connected
by two inter-domain loops (Peisach et al., 1998; Okada et al.,
2001; Goto et al., 2003; Hirotsu et al., 2005; Boyko et al., 2016)
(Figure 2).
The small domain (residues 1–119 and 287–292 in GEO1900)
is composed of three α-helices wrapped around a seven
stranded antiparallel β-sheet with topology −1, +4x, +1,
−2x, −1, +4x as defined by PROMOTIF (Richardson, 1981;
Kabsch and Sander, 1983; Hutchinson and Thornton, 1996)
with the C-terminus contributing to the last β-strand. The
large PLP-binding domain (residues 130–285) has six α-helices
surrounding an eight stranded β-sheet with topology −1x,
−1, +5, +1, +1, −3, −1 and direction − + + + − + −.
Both domains are connected via a short link at C-terminus
(residues 286–287) and a long inter-domain loop (residues
120–129).
Quaternary Structure of BCATs
A dimer formation is required for the BCAT catalytic activity,
since residues from both subunits in the dimer contribute to
the active site (Figure 3). However, both GEO1900 and AF0933
form hexamers (trimers of dimers) in the crystal (Figure 4),
with the GEO1900 hexamer located on a crystallographic dyad.
Dimerization of GEO1900 results in 2400 Å2 or 18% of each
subunit solvent accessible surface area being buried (Krissinel
and Henrick, 2007). Hexamer formation of GEO1900 in the
crystal leads to an additional 14% of each subunit surface area
being buried. Similarly, dimerization of AF0933 buries 19% of
subunit surface area with additional 14% buried upon hexamer
formation. This is very much in line with other bacterial BCATs
that form a hexameric structure in the crystal (Okada et al., 2001;
Chen et al., 2012; Boyko et al., 2016), with organization of all
hexamers being very conserved, the core rmsd in Cα positions are
comparable for both dimers and hexamers in pairwise alignment.
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FIGURE 2 | A cartoon representation of the subunit of GEO1900 with the
large domain shown in gold and the small domain shown in ice blue. The
loops connecting the domains are shown in coral. The cofactor PLP and the
active site lysine 152 are shown as stick models with carbon atoms shown in
green. Figures 2–5, 7, 8 are drawn using CCP4mg (McNicholas et al., 2011).
Interestingly, known structures of other members of group IV
proteins—D-amino acid TAms, bacterial and fungal amine TAms
are homodimers (Peisach et al., 1998; Sayer et al., 2014; Thomsen
et al., 2014). In this context a dimeric structure in solution
observed by size exclusion chromatography for GEO1900 and
T. uzoniensis BCAT (Boyko et al., 2016), and a small dimeric
fraction for AF0933 suggests an equilibrium between hexameric
and dimeric forms, since only dimer is required for catalysis.
The AF0933 is predominantly hexameric in solution (Figure S2)
which may account for its increased thermal optimum over that
of GEO1900.
Active Site
The active site of the archaeal BCATs is located at the bottom of
the cleft formed by residues of both domains of one subunit as
well as of the small domain of an adjacent subunit within the
catalytic dimer. The same arrangement has also been observed
in other BCATs (Okada et al., 2001) and generally in all enzymes
with a PLP type IV fold (Peisach et al., 1998; Sayer et al., 2014;
Thomsen et al., 2014). A PLP molecule is covalently bound to the
catalytic Lys152 in the GEO1900 active site (Lys150 in AF0933).
Since most active site residues are conserved between the two
BCATs the GEO1900 numbering will be used henceforth.
In the holo and complex structures of the archaeal BCATs
the PLP moiety is clearly visible in the electron density map
and has B factors similar to those of the neighboring protein
residues, indicating a full occupancy of the cofactor. The PLP
FIGURE 3 | A cartoon representation of the dimer of the AF0933 BCAT
gabaculine complex. The gabaculine-PLP covalent adduct molecules are
shown as spheres.
FIGURE 4 | A cartoon representation of the AF0933 BCAT holo structure in
the native hexameric form. The PLP cofactor molecules are shown as spheres.
forms a number of contacts with the protein molecule as found
in other BCATs (Hutson, 2001; Okada et al., 2001; Yennawar
et al., 2001). Apart from the Schiff base formed by the NZ of
Lys152 residue, the pyridine ring of the cofactor forms hydrogen
bonds to the conserved Tyr156 and Glu185 residues. The PLP
phosphate group forms a salt bridge with Arg53 and a number
of hydrogen bonds to the main chain nitrogens and side chains
of residues Thr212 and Thr248, and the main chain nitrogen
of Ile211, and two water molecules (Figure S8). The active
site of BCAT can be subdivided into two pockets, A and B.
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In GEO1900, the B-pocket is formed by the residues Gly36,
Arg38, Tyr89, Gly188, Thr248, and Ala249 (Figure S8). When
compared to the structure of E.coli BCAT (Okada et al., 2001)
these residues are found to be involved in the binding of the
substrate carboxyl group. The A-pocket is lined by conserved
residues Arg91, Tyr29′, Phe34, Trp120, and Tyr124 as well as the
non-conserved residues Leu101′ and Leu103′ (where ′ denotes-
residues of another subunit).
Ligand Binding and Enzyme Negative
Cooperativity
A bound AKG molecule is clearly visible in the electron density
(Figure 1) of one subunit of the GEO1900_AKG complex and has
a B-factor comparable to the average for the protein. A contact
analysis reveals that α-carboxylic as well as α-keto groups of the
ligand are tightly bound in the active site via hydrogen bonds
with the highly conserved residues Tyr89, Ala249, Thr248, Arg91
as well as Ala250 and Gly188 (via a conserved water molecule
D238) (Figure S8). Although most of the residues around the γ-
carboxylic group of the ligand are hydrophobic, this group is also
connected to the protein via several hydrogen bonds with Arg91,
Tyr29′ and Leu103′ (via the water molecule–D923).
Comparative analysis of the holo form of GEO1900 and its
complex with AKG reveals that the binding of the acceptor
substrate does not result in any significant conformational
changes in the active site, except for the rotation of the side
chains of Leu101′ and Leu103′, accompanied by a small main
chain displacement (distance between corresponding Cα-atoms
is about 0.6 Å). In addition the AKG binding residues 120–124 of
the inter-domain loop shift toward the active site. This positions
the side chains of residues Trp120 and Leu123 so that they shield
the ligand from the solvent (Figures S9, S10). Interestingly, in the
case of the two archaeal BCATs the residues Leu123 and Tyr124
are not part of the consensus sequence X-G-X-Y-L (where the
first X is an aromatic residue) which is typical of other BCATs,
rather this motif is X-G-X-L-Y in both GEO1900 and AF0933.
This permutation (Tyr to Leu and vice versa) leads to a change
in the shape of the active site cavity, making the A-pocket more
extended in the direction of Leu123.
The inhibitor gabaculine makes an irreversible complex with
the cofactor PLP due to the migration of the double bond of the
external aldimine onto the gabaculine ring (Figure 5). However,
the PLP-gabaculine adduct in the AF0933 complex structure has
only partial occupancy of the gabaculine in the enzyme active site.
Occupancy of the ligand in subunit F is below the level for an easy
build into the model structure, therefore the internal aldimine
was modeled into this subunit. The active site of the AF0933
BCAT is much more restrictive for binding of the gabaculine
moiety than that of the fungal (R)-selective ωTAm from Nectria
haematococca previously studied by us where it was found at
100% occupancy (Sayer et al., 2014). However, when 100:1 excess
of gabaculine to PLP was added to the crystallization droplet it
was expected to find full occupancy of the PLP-ligand adduct,
unless AF0933 BCAT exhibits some negative cooperativity for
substrate binding. Binding of the gabaculine inhibitor to one
BCAT subunit appears to be sensed by neighboring subunits,
FIGURE 5 | A view from outside onto the active site cavity entrance using a
surface representation of the AF0933 BCAT complex with the inhibitor
gabaculine (shown as spheres).
with conformational adjustments preventing the binding of the
inhibitor in the other subunits. Negative cooperativity has been
reported earlier for other PLP enzymes (Stetefeld et al., 2006;
Ruzicka and Frey, 2010) and is in agreement with the fact that the
AKG binding in the GEO1900 complex structure in only found
in one of the three subunits.
Inter-domain Loop Conformation
The conformation of the loop 121–129 is significantly different
between the BCAT enzymes and other class IV enzymes such
as (R)-selective Nectria TAm where this loop covers the active
site, creating an enclosed environment which would facilitate the
activation of the amine nitrogen. In the AF0933 BCAT enzyme
this loop is poorly ordered and moves away from the active
site. In other BCATs including the GEO1900 BCAT this loop is
closer to the active site but does not cover it as tightly as seen
in the Nectria TAm. However, the loop appears to become more
ordered in the GEO1900_AKG complex.
Comparison of Structures of the Native
Enzymes and the Complexes of GEO1900
and AF0933
From biochemical analysis it is known that AKG does not
inhibit the activity of GEO1900 in the concentration range
tested (Figure S11). It would appear that the crystal contacts
play a role in increasing the affinity of GEO1900 toward AKG
in one single subunit of the enzyme. Superposition of the
subunits from the asymmetric unit gave a RMSD between the
Cα atoms of about 0.2 and 0.5 Å in case of GEO1900_holo and
GEO1900_AKG, respectively. In the case of the GEO1900_holo
structure the conformations of the flexible loops have small
differences between the different subunits. However, these are
likely to be due to crystal packing effects. The structure of the
complex GEO1900_AKG demonstrates that a major difference
between the subunits can be assigned to a movement of the inter-
domain loop which has a sufficiently different conformation in
subunit A (as shown in Figure S9), where the ligand was bound,
when compared to the other subunits. This loop was reported to
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shield the active site from the solvent upon the substrate binding
(Hirotsu et al., 2005). There are two further differences between
the GEO1900_AKG and GEO1900_holo structures. The first is
the conformation of the loop 264–266, which differs in the A
subunit when compared to subunits B and C, with a distance
between the matching Cα-atoms of 1.0 Å. The second difference
is in the region of residues 249–252, where the distance between
corresponding Cα-atoms of the different subunits reaches 0.6
Å. As the residue displacements were only observed for the A
subunit containing bound AKG, it is suggested that this could be
the result of main-chain movement due to the substrate binding.
Superposition of the GEO1900_holo subunits on the
GEO1900_AKG subunits reveals a further major difference in
the orientation of the inter-domain loop. This loop is usually
disordered in the absence of a bound substrate (Okada et al.,
2001; Chen et al., 2012) with exception of the structure of the
BCAT from the archaeon T. uzoniensis (PDB ID 5CE8; Boyko
et al., 2016). In the GEO1900_holo structure the inter-domain
loop is not seen in the electron density for subunits A and C,
but in subunit B only two residues 120–121 are not observed
(Figure S9). The other residues of the inter-domain loop have
higher B factors than the average B factor of the model. It is
proposed that the changes in the conformation of the inter-
domain loops in GEO1900_AKG reflect the structuring of this
loop during substrate binding. Thus, in the A subunit this
loop adopts a conformation which shields the bound substrate
from the solvent. However, in the B subunit of the complex the
conformation of inter-domain loop is similar to that found in
subunit B of the holo_GEO1900 structure. In the C subunit this
loop is not seen in the electron density.
Although the AF0933 BCAT GABC complex was obtained
by co-crystallization with gabaculine, differences in the main
chain atom positions between the holoenzyme structure and the
complex are minimal. No movement of the interdomain loop
upon formation of the PLP-gabaculine complex was observed.
The carboxyl group of the gabaculine-PLP adduct points away
from both distal and proximal carboxyl group binding pockets of
the BCAT. This is probably due to the orientation of this adduct
being sterically hindered by the shape of the AF0933 BCAT active
site cleft.
Comparison to Structures of Other BCATs
and Other CLASS IV Transaminases
The BLAST search found several BCATs with known three-
dimensional structure which have a moderate primary sequence
similarity to GEO1900 and AF0933. The structure-based
sequence alignment (Figure 6), shows the comparison of the
GEO1900 and AF0933 sequences with other BCATs and another
class IV TAm enzyme from the fungal speciesNectria. This shows
that the Nectria enzyme has an extended N-terminus and also
a difference in the loop residues 99–108 (AF0933 numbering)
between β5 and β6 of the N-terminal small domain. This loop
contributes to the active site and is much larger in the GEO1900
and AF0933 BCATs (Figure 7).
The superposition of the GEO1900_holo subunit and the
subunits of the AF0933 and other homologous enzymes using
PDBeFOLD showed that the fold of the new thermostable BCATs
is very similar to related enzymes. Small differences are observed
within the flexible loops that connect the secondary structure
elements. However, the inter-domain loop conformation is
similar between GEO1900_AKG and the complexes of the E.coli
BCAT with substrates bound (PDB codes−1I1M and 1I1L).
A comparison of the structures of GEO1900 and AF0933 has
been made with other class IV TAms. The overall structures of
these enzymes are similar for DATAs, BCATs and (R)-selective
amine:pyruvate TAms. It appears that the differences are in the
amino acid residues lining the active site cavity that determine
substrate specificities. The BCAT catalyzed transamination
between branched chain L-amino acids and the AKG acceptor
produces the branched chain ketoacid and L-glutamate. The
DATAs catalyze the exchange of the amino group between D-
amino acids and the AKG. The (R)-selective amine:pyruvate
TAms catalyze transfer of an amino group between a (R)-ω-
substrate and pyruvate. Höhne et al. (2010) have identified two
signaturemotifs which distinguish the BCAT andDATA enzymes
from other (R)-specific amine:pyruvate TAms such as theNectria
TAm (Sayer et al., 2014). The conserved Nectria TAm residues
His53, Tyr58, and Val60 belong to the first signature motif
and Phe113 to the second motif. These residues contribute to
the surfaces of the A and B substrate binding pockets of the
active sites to enforce specific binding of the (R)-amine. The
residues Ser62 from the first signature motif and Glu115 from
the second motif, in the Nectria TAm prevent the BCAT activity
for this enzyme. In the BCATs the equivalent residues Arg38 and
Arg91 (GEO1900 numbering) are responsible for binding the
α-carboxyl and the γ-carboxyl groups of the substrate.
Structural Basis for GEO1900 and AF0933
Thermostability
Both BCATs GEO1900 and AF0933 demonstrate high thermal
and solvent stability. The closest sequence homologs of these
enzymes with a known 3-D structure are from another
thermostable archaeal BCAT from T. uzoniensis (45% sequence
identity to AF0933; Boyko et al., 2016), Thermus thermophilus
(42% identity; PDB ID: 2EIY) and a mesophilic E. coli BCAT
(40% identity; Okada et al., 2001). Thermostability of the E.
coli BCAT does not appear to have been reported, however
one can assume it is significantly lower than that of its
counterparts from thermophilic organisms, although in some
cases such presumption may be erroneous. For instance, the
E. coli tryptophanase has high thermostability and was purified
using a heat treatment step (Dementieva et al., 1994).
Features that are known to confer increased thermostability
of proteins include an increase in ionic interactions or salt
bridges which offer more thermostability when found in clusters,
increased hydrophobicity and the shortening of surface loops
(Littlechild et al., 2013). The AF0933 TAm subunit forms up to
27 ion pairs, with five 3-amino acid salt bridge clusters formed.
There are no ion pairs between the subunits in the catalytic
dimer, however three ion pairs per subunit are formed with
neighboring subunits within the hexamer. Residues withmultiple
side chain conformations in many cases form ion pairs with
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FIGURE 6 | Multiple sequence alignment of different BCATs, A. flugidus, G. acetivorans, T. thermophilus, E.coli, T. uzoniensis, N. haematococca. Arrows indicate
β-strands, and helical curves denote α-helices of the structure of AF0933 above and Nectria TAm below. The active site lysine is highlighted in red. The figure was
prepared with ESPript3 (Robert and Gouet, 2014).
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FIGURE 7 | An overlay of the Cα trace of the AF0933 BCAT (green and coral coil) gabaculine complex with the Nectria TAm (ice blue and gold coil) gabaculine
complex (Sayer et al., 2014) to illustrate the differences between the ligand and loop conformations within the active site between the two enzymes. The PLP
gabaculine adduct is shown as a stick model for the AF0933 BCAT structure and as thick lines for the Nectria amine TAm structure. Interdomain loops and the loop
connecting β5 and β6 of the N-terminal small domain of the adjacent subunit in the catalytic dimer covering the active site cavity, have different conformation between
the AF0933 BCAT and the Nectria TAm as shown.
different residues for either conformation. The E.coli BCAT has
15 ion pairs altogether, including those involved in four 3-amino
acid clusters. None of these are with neighboring subunits. Most
of salt bridges and other structural features observed in the
AF0933 are conserved in GEO1900, therefore comparison here
is limited to the former protein.
The AF0933 BCAT has much shorter loops connecting
secondary structure elements in comparison with the E. coli
BCAT. Particularly shortened are the loops connecting strands
β3 to β4 and β5 to β6 of the N-terminal domain and β5 toβ6
of the large domain. The C-terminal inter-domain loop, which
is only 2 residues long in the AF0933 BCAT, is 9 residues
long in the E. coli enzyme. Shorter loops also mean that there
is a higher percentage of residues belonging to the secondary
structure, 55.9% in AF0933 BCAT compared to 49.2% in the E.
coli BCAT. The inter-subunit interface in the catalytic dimer is
mainly hydrophobic both in the AF0933 and in the E. coli BCAT,
therefore it appears that hydrophobic interactions contribute
equally to the stability of both proteins.
Thus, an increased number of ion pairs per subunit alongside
shorter surface loops are the main contributing factors to the
increased thermostability of AF0933 when compared to the E.coli
BCAT.
Application to Biocatalysis
Both GEO1900 and AF0933 make a good thermostable and
solvent tolerant scaffold which can be optimized for production
of natural and synthetic chiral amines of interest to the
pharmaceutical industries. The new BCAT enzymes have a chiral
preference for the (R)-isomer of MBA but with low activity.
However, they offer the possibility to be further optimized for this
and other substrates of interest using the knowledge of the active
site cavity obtained from the current structural studies. The active
site cavities of GEO1900 and AF0933 can be extended to better
accommodate MBA and other bulky substrates. The comparison
of GEO1900 and AF0933 with a (R)-specific TAm from a Nectria
sp. shows that this fungal enzyme has an additional long N-
terminal α-helix that increases the depth of the active site of this
enzyme. The presence of this N-terminal helix shown in Figure 8,
a much tighter closure over the active site of the interdomain
loop, and a different conformation of the loop between β5 and
β6 of the N-terminal small domain, creates a difference in the
substrate environment of the Nectria TAm in comparison with
that in the GEO1900 and AF0933 BCATs. This would potentially
alter the local dielectric constant within the fungal enzyme active
site thereby facilitating the observed amination reactions of ω-
keto acids and different aldehydes and ketones by this TAm
(Sayer et al., 2014).
CONCLUSIONS
The approach developed in the THERMOGENE project was to
search for these new archaeal TAm enzymes within the untapped
resource of “natures” biodiversity in order to find enzymes that
have evolved to be active under the extreme growth conditions
of their host organisms. This approach has been successful
and has resulted in the discovery of new thermostable BCATs
displaying new features which would have been missed in a
directed evolution approach using already identified mesophilic
enzymes. The thermophilic archaea G. acetivorans and A.
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FIGURE 8 | A cartoon representation of the superimposition of the catalytic
dimers of the AF0933 gabaculine complex with the Nectria TAm gabaculine
complex, illustrating the additional α-helix at the N-terminal region of Nectria
TAm as shown in Figure 6. The PLP gabaculine adduct is shown in ball and
stick mode.
fulgidus were isolated from different hydrothermal sources. The
G. acetivorans has been isolated from samples of deep-sea
hydrothermal vents of the Ashadze field, the deepest of the
knownWorld Ocean hydrothermal fields (Querellou et al., 2009)
whereas the A. fulgidus was isolated in shallow hyperthermal
sea water vents in Volcano Island in Sicily (Stetter, 1988) yet
they have related BCAT enzymes with 79% sequence identity
and similar properties. The GEO1900 and AF0933 enzymes
have been characterized both biochemically and structurally.
They both demonstrate significant thermostability and organic
solvent stability and are promising candidates for industrial
applications. Both the AF0933 and the GEO1900 are very
thermostable as determined by the stability trials conducted. The
AF0933 is a hexamer in solution as measured by gel filtration
studies whereas the GEO1900 is mainly found as a dimer.
The crystallographic studies have provided structures of both
enzymes in the internal aldimine form, to 1.9 Å resolution
for the Geoglobus enzyme and 2.0 Å for the Archaeoglobus
enzyme. The structures of the enzymes with substrate and
inhibitor have revealed the conformational changes occurring
in the enzymes during catalytic turnover. A comparison of the
Archaeoglobus inhibitor complex structure with the related (R)-
selective fungal Nectria enzyme structure has produced further
insights into differences in substrate specificity between the two
enzymes. The new robust (R) selective BCAT enzymes will add
to the enzyme “tool box” available for industrial biocatalysis
and will have applications for production of new important
chiral intermediates for the pharmaceutical industries using a
sustainable route.
MATERIALS AND METHODS
All reagents were purchased from Sigma–Aldrich, Buchs,
Switzerland unless otherwise stated. The chromatography
columns were obtained from GE Healthcare (Little Chalfont,
UK).
Expression and Purification
One gene encoding a class IV transaminase was identified in the
complete genome sequence of G. acetivorans (Mardanov et al.,
2011) by the BLAST search (Altschul et al., 1990). The nucleotide
sequence of this gene was synthesized for optimal expression in
E. coli. The GEO1900 was cloned into the BamHI and HindIII
sites of the expression vector pQE30 (Qiagen, Manchester, UK).
The encoded recombinant protein contained an N-terminal
MRGSHHHHHHGS tag. The E. coliDLT1270 cells harboring the
expression vector pQE30_GEO1900 were grown in LB medium
at 37◦C, containing 100 µg ml−1 ampicillin, to an OD600 of 0.5.
Protein expression was induced by addition of 1mM Isopropyl-
β-d-thiogalactopyranoside (IPTG) for 19 h at 37◦C. The cells
were harvested by centrifugation. The cell paste was resuspended
in 50mM Tris-HCl buffer, pH 7.5, containing 500mM NaCl,
2Murea, 20mM imidazole, 2mM β-mercaptoethanol, 0.1% (v/v)
Triton X-100, and 1mM phenymethylsulfonyl fluoride (PMSF).
After the cells were disrupted by sonication the crude cell extract
was centrifuged at 10,000 g for 25min. The filtered supernatant
was applied to aHi-Trap chelatingHP column (2ml) equilibrated
in 50mM Tris-HCl, pH 7.5, containing 500mM NaCl, 20mM
imidazole, and 0.1% (v/v) Triton X-100. The (His)6-tagged
recombinant GEO1900 was eluted with a linear gradient from
20 to 500mM imidazole in the same buffer but without Triton
X-100. The active fractions were pooled and incubated with
1mM PLP for 1 h at 40◦C, concentrated using a 30 kDa cut-off
centrifugal filter device (Millipore), and applied to a Superdex 200
column (GE Healthcare) equilibrated in 30mM Tris-HCl, pH
8.0, supplemented with 300mM NaCl. The fractions containing
the holo GEO1900 protein were stored at −20◦C with the
addition of 50% glycerol. The protein purity was analyzed by
SDS-PAGE (12%). The protein concentration was determined
spectrophotometrically using the calculated extinction coefficient
of 24,955 M−1 cm−1.
Another class IV transaminase gene was identified by
searching known thermophilic archaeal genomes using the BCAT
from N. haematococca as a query sequence. This identified a
290 amino acid protein in A. fulgidus (Klenk et al., 1997).
The nucleotide sequence of this gene was synthesized for
optimal codon usage for expression in E. coli. The expression
of recombinant AF0933 was carried out using the plasmid
pLATE51-AF0933 (Thermo Fisher Scientific, Ashford, UK)
which was transformed into E. coli Rosetta (DE3)-pLysS
(Novagene). Cells were grown in 1.6 l LB medium at 37◦C to an
OD600 of 0.4–0.6 and expression was started by the addition of
1mM IPTG. After 4.5 h of further growth, cells were harvested
by centrifugation (max 9,800 × g at 18◦C). The E. coli pellet
was suspended in 50mM Tris-HCl, pH 8.2, containing 300mM
NaCl and 10mM imidazole (buffer A). Cell disruption was
performed by passing through a French pressure cell (16,000
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psi) followed by centrifugation (max 48,000 × g at 4◦C). The
supernatant was incubated for 20min at 70◦C to precipitate E.coli
proteins and centrifuged (max 48,000 × g at 4◦C). The resultant
supernatant was applied to a 1ml nickel-nitrilotriacetic acid (Ni-
NTA) column (Qiagen, Manchester, UK) equilibrated in buffer
A using the ÄKTA FPLC system. After a washing step, protein
was eluted by stepwise increase of the imidazole concentration
up to 500mM. The fraction containing the highest enzyme
activity was applied to a Superdex 200 HiLoad size exclusion
column (1.6 × 60 cm) equilibrated with 50mM Tris-HCl, pH
7.5, containing 500mM NaCl and 0.05mM PLP (GE Healthcare,
Little Chalfont, UK). The protein purity was analyzed by SDS-
PAGE (12%). Protein concentration was determined by using the
Bradford method (Bradford, 1976) or spectrophotometrically for
the purified protein.
Enzyme Activity Assays
The overall transamination reaction of GEO1900 was assayed
by a discontinuous method by measuring the rate of formation
of L-glutamic acid from AKG in the presence of BCAAs in
the direct reaction or the formation of AKG from L-glutamate
acid in the presence of keto acids in the reverse reaction. In
the direct reaction assay GEO1900 (5–30 µg) was pre-incubated
in 1ml of the reaction mixture, containing 50mM phosphate
buffer, pH 8.0, 100mM NaCl, 60µM PLP, and 5mM of the
amino acid at 65◦C for 3min. The reaction was initiated by the
addition of 5mM AKG. Samples (100–300 µl) were taken at
different time points and frozen to stop the reaction. Then the
L-glutamic acid concentration was evaluated in the samples after
dilution to 1ml by spectrophotometry employing the glutamate
dehydrogenase (GluDH) assay at 25◦C in 50mMTris-HCl buffer,
pH 9.0, supplemented with 1mM NAD and 0.5U GluDH. In the
reverse reaction assay the enzyme (5–30 µg) was preincubated in
the reaction mixture (1ml) containing 50mM phosphate buffer,
pH 8.0, 100mM NaCl, 60µM PLP, and 5mM L-glutamic acid
at 65◦C for 3min. The reaction was initiated by the addition
of 5mM ketoacid. Samples (100–300 µl) were taken at several
time points and frozen to stop the reaction. The α-ketoglutarate
concentration was evaluated in the samples after dilution to 1ml
by spectrophotometry employing the GluDH assay at 25◦C in
20mM sodium phosphate buffer, pH 7.3, supplemented with
0.09mMNADH, 30mM ammonium chloride and 0.5U GluDH.
The specific activity of GEO1900 was calculated from the initial
linear region of the progress curve of the L-glutamic acid/ α-
ketoglutarate formation.
Steady-state kinetic parameters for pyruvate and AKG were
determined from the substrate saturation curves for the overall
reaction between the keto substrate and 5mM L-Leu as a
co-substrate. The saturation curves were analyzed using the
Michaelis-Menten model. The GEO1900 activity toward (R) and
(S)-MBA was measured spectrophotometrically at 65◦C by the
acetophenone assay (Schätzle et al., 2011; Boyko et al., 2016).
The AF0933 BCAT activity was measured as 3-methyl-2-
oxobutyrate dependent formation of AKG from L-glutamate.
One unit of enzyme activity corresponded to the conversion
of 1 µmol of substrate consumed or product formed per min.
The standard assay mixture contained 0.1M Tris-HCl, pH 8,
0.1mM PLP, 5mM 3-methyl-2-oxobutyrate, 10mM L-glutamate
and protein. Samples were incubated at 70◦C up to 40min, the
reaction was stopped on ice and the amount of AKG formed was
quantified by measuring NADH consumption in the reductive
amination of AKG to L-glutamate at 340 nm. The quantification
mixture (0.3ml) was incubated at 20◦C for 10min and contained
0.1MTris-HCl, pH 7.5, 0.3mMNADH, 40mMNH4Cl, 5–100µl
of the samples and 0.32U of L-glutamate dehydrogenase. Protein
was determined by the Bradford method.
Kinetic constants for 3-methyl-2-oxobutyrate, 4-methyl-2-
oxopentanoate and 3-methyl-2-oxopentanoate were determined
with substrate concentrations up to 15mM, 10mM L-glutamate
and 0.7–4 µg protein using standard conditions. Kinetic
constants for L-glutamate were determined with substrate
concentrations up to 80mM, 5mM 3-methyl-2-oxobutanoic acid
and 2.7–9.1 µg protein using standard conditions. The substrate
specificity was tested with 1 or 10mM amino acceptors, 2.5 µg
protein using standard conditions.
The reverse reaction was measured as L-valine dependent
decrease of AKG. The assay mixture contained 0.1M Tris-HCl,
pH 8.0, 0.1mM PLP, 10mM L-valine, 10mM AKG and 5.3 µg
protein. Standard conditions were used for further incubation
and quantification.
AF0933 activity was also measured as 3-methyl-2-oxobutyrate
dependent formation of pyruvate from L-alanine. The assay
mixture contained 0.1M Tris-HCl, pH 8.0, 0.1mM PLP, 5mM
3-methyl-2-oxobutyrate, up to 20mM L-alanine and 2.7 µg
protein. Samples were incubated at 70◦C up to 20min, the
reaction was stopped on ice and the amount of pyruvate formed
was quantified by measuring the reduction of pyruvate to lactate
at 340 nm. The quantification mixture (0.3ml) was incubated
at 20◦C for 10min and contained 0.1M Tris-HCl, pH 7.5,
0.3mM NADH, 15–100 µl of the samples and 1.8U of L-lactate
dehydrogenase (Roche, Burgess Hill, UK).
The AF0933 activity with (R) and (S)-MBA was determined
by the acetophenone assay. The assay mixture of 1ml contained
0.1M Tris-HCl, pH 8.0, 0.1mM PLP, 2mM 3-methyl-2-
oxobutyrate, 2-oxobutyrate or pyruvate as amino acceptor, 2mM
(R)-MBA or (S)-MBA as amino donor and 16 µg protein.
Samples were incubated at 65◦C up to 180min, the reaction was
stopped on ice and the absorbance was measured at 245 nm. The
molar extinction coefficient of 11.6 mM−1 cm−1 was used for
acetophenone.
Effects of pH, Temperature, and Solvents
on the Transamination Reaction
The pH optimum of the reaction for GEO1900 with 5mM L-Leu,
and 5mM AKG was determined at 65◦C using 50mM sodium
phosphate, pH 6.0–8.0, 50mM BICINE containing 100mM
NaCl.
The temperature optimum of the transamination reaction
between 5mM L-Leu, and 5mM AKG was determined in the
temperature range from 40 to 95◦C in 50mM phosphate buffer,
pH 7.9, supplemented with 100mM NaCl. The thermostability
of GEO1900 was determined by incubating a 1.0 mg/mL
enzyme samples in 100mM phosphate buffer, pH 8.0 at different
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temperatures between 30 and 70◦C for 2 h. After the thermal
treatment, the remaining enzyme activity was determined at
65◦C as described above.
The pH optimum of AF0933 was determined with 3.6 µg
protein, standard conditions and the following buffers each at a
concentration of 0.1 M: MES (pH 5.5, 6.0, 6.5), Bis-Tris (pH 6.5,
7.0), HEPES (pH 7.0, 7.5, 8.0), Tris-HCl (pH 7.5, 8.0, 8.5), Bicine
(pH 8.5, 9.0) and Piperazine (pH 9.0, 9.5, 10.0).
The temperature optimum of the reaction of AF0933 was
determined between 50◦C and 95◦C in 0.1M HEPES, pH 7.0,
containing 0.1mM PLP, 5mM 3-methyl-2-oxobutyrate, 10mM
L-glutamate and 2.7–5.4 µg protein.
The thermostability of AF0933 was measured between 55 and
95◦C, therefore protein was incubated in 3 volumes of buffer
(0.1M HEPES, pH 7.0 adjusted to the respective temperature)
up to 120min. Samples (2.8 µg protein) were chilled on ice and
remaining BCAT activity was determined in 0.1M HEPES, pH
7.0 using standard conditions.
The influence of solvents (ethanol, DMSO, methanol and
acetonitrile) on activity was analyzed between 10 and 50%
solvent. The respective solvents were incubated with 2.2 µg
protein (for AF0933) and 50 µg protein (for GEO1900) for 1 h
at 20◦C and 55◦C then remaining activity was measured with
standard conditions.
Protein Crystallization
For crystallization fractions of GEO1900 after the size-exclusion
chromatography step were concentrated up to 10 mg/ml using
an Amicon Ultra 30 kDa MWCO (Merck Millipore, Darmstadt,
Germany) centrifugal filter units and stored at −70◦C in 30mM
Tris-HCl buffer, pH 8.0, supplemented with 300mM NaCl and
100µM PLP. High-throughput crystallization screening was
setup using a robotic system (Rigaku Automation, USA) at the
Resource Centers division of the NBICS Centre of the National
Research Centre “Kurchatov Institute” (Boyko et al., 2013). The
sitting-drop vapor-diffusion method was applied at 20◦C in 96-
well CrystalMation plates (Rigaku Automation, USA). The first
round of the screen resulted in three in the following conditions:
(1) 0.2M TMAO, 0.1M Tris-HCl, pH 8.5, 20% PEG 2000MME;
(2) 30mM citric acid, pH 3.0; 70mM Bis-tris propane, 20%
PEG 3350; (3) 0.2M KCl; 0.1M ammonium sulfate, pH 7.5;
20% 2-propanol, pH 7.5. Crystals grown under conditions (1)
and (2) had rod-like shape with bad surface morphology and
tended to form clusters. Under condition (3) numerous cube—
like crystals were grown with the dimensions of 20 × 20 ×
20µm. The further optimization was made using the hanging-
drop vapor-diffusion technique in 24-well VDX plates (Hampton
Research, Aliso Viejo, California, USA) at 20◦C by varying
ammonium sulfate concentration, pH of the reservoir solution
and addition of organic compounds. Crystals suitable for X-ray
diffraction appeared in 3 months in the 3 µl drop with protein
to precipitant ratio of 1:1 equilibrated over 500 µl of reservoir
solution. The crystals used for data collection grew in (1) 0.1M
Tris-HCl pH 8.0, 12% glycerol, 1.5M ammonium sulfate, and
(2) 0.1M HEPES, pH 7.5; 0.7M lithium sulfate. Crystals of
GEO1900 grown under condition (1) (GEO1900_holo) were
briefly soaked in mother liquor containing 30% glycerol as a
cryoprotectant. To obtain the complex of GEO1900 with AKG
crystals from condition (2) were soaked for 20min in the mother
liquor supplemented with 50mM AKG (GEO1900_AKG) then
transferred into a cryoprotectant containing the same solution
with addition of 30% ethylene glycol. Crystals were flash-cooled
to 100K in liquid nitrogen immediately prior to the X-ray
experiment.
Prior to crystallization the AF0933 enzyme was concentrated
to ∼10mg ml−1 using a 10 kDa Vivaspin membrane
(Vivaproducts, Littleton, Massachusetts, USA). Microbatch
crystallization trials were set up using an Oryx 6 crystallization
robot (Douglas Instruments, Hungerford, England) using the
JCSG+ screen (Molecular Dimensions, Newmarket, England)
(Newman et al., 2005). The droplet consisted of a 50:50 ratio of
protein solution to screen solution and was covered with Al’s oil
(50:50 mixture of silicone oil and paraffin). The crystallization
plates were stored at 18◦C and were regularly checked for
appearance of crystals under a light microscope.
Crystals of the AF0933 holoenzyme were grown using several
different PEG and methylpentanediol (MPD) conditions. The
best crystals grew in 100mM cacodylate buffer pH 6.5, 200mM
magnesium chloride and 50% v/v PEG200. To obtain the
inhibitor bound complex AF0933 was co-crystallized with 5mM
gabaculine under the same conditions.
Data Collection and Processing
The GEO1900 data were collected at the BL41XU beamline
of the Spring8 synchrotron (Harima, Japan) using a Pilatus
detector. The data were indexed, integrated, and scaled using
XDS (Kabsch, 2010) for the holo enzyme and using Mosflm
(Battye et al., 2011) for the complex with AKG. The data showed
both structures were not twinned, based on the L-test (Padilla and
Yeates, 2003). The program Pointless (Evans, 2006) suggested the
P3121 space group or its enantiomorph P3221.
Data for AF0933 were collected on beamline I04-1 at the
Diamond Synchrotron light source (Oxford, UK) under cryo
conditions (100K in a stream of gaseous nitrogen). Data were
processed using XDS (Kabsch, 2010) and AIMLESS (Evans and
Murshudov, 2013) in the Xia2 pipeline (Winter et al., 2013).
Further data and model manipulation was carried out using the
CCP4 suite of programs (Winn et al., 2011). The data collection
and processing statistics for both GEO1900 and AF0933 are
summarized in Table 3.
Structure Solution and Refinement
The structure of GEO1900_AKG was solved at 2.2 Å resolution
by the molecular replacement (MR) method using the BALBES
MR pipeline (Long et al., 2007), the MR search was carried
out in both enantiomorph space groups. The solution was
found in P3221 with the atomic model of BCAT from T.
thermophilus (PDB ID: 2EIY), which shares 42% of amino acid
sequence identity with GEO1900, and was refined to an R-free
of 37.7% without any model rebuilding, the BALBES estimation
of probability of correct solution was 99%. The GEO1900_holo
structure was solved to 2.2 Å by MR with the atomic coordinates
of GEO1900_AKG.
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The AF0933 holo-structure was phased by MR implemented
in MOLREP (Vagin and Teplyakov, 2010) using a sequence
modified model (Lebedev et al., 2008) of a dimer of N.
haematococca TAm [31% sequence identity; PDB ID 4CMD;
(Sayer et al., 2014)] as a model. The gabaculine inhibitor bound
complex of AF0933 crystallized in the same space group P212121.
Refinement of all structures was carried out with REFMAC5
(Murshudov et al., 2011). The manual rebuilding of the
models into electron density maps was carried out with the
COOT interactive graphics program (Emsley et al., 2010). The
final refinement cycles of the GEO1900_holo structure were
conducted with inclusion of hydrogen atoms in riding positions.
The 6-fold NCS averaging by DM (Cowtan, 2010) was used
for phase improvement of AF0933 structures. The resulting
phases from density modification were used for phase refinement
in REFMAC5 (Pannu et al., 1998). BUSTER refinement maps
(Bricogne et al., 2016) were used for building better positioning of
poorly defined loops and of the inhibitor with partial occupancy
in the AF0933 active site.
Structure Analysis and Validation
PROCHECK was used for assessment of the quality of the
models (Laskowski et al., 1993). Images were created with
CCP4mg (McNicholas et al., 2011) and PyMOL molecular
graphics system (Schrödinger, LLC). A visual inspection of the
models was performed using the PyMOL and COOT software.
The BLAST service (Altschul et al., 1990) was used for the
amino acid alignment. The structure superposition was carried
out using the PDBeFOLD program (Krissinel and Henrick,
2004). The contacts were analyzed usingWHATIF (Vriend, 1990)
and PISA (Krissinel and Henrick, 2007) software. The ligand
coordination was visualized by LigPlot (Laskowski and Swindells,
2011).
The atomic coordinates and structure factors for both
GEO1900 and AF0933 have been deposited in the Protein Data
Bank. The PDB codes for GEO1900 holo enzyme as 5CM0
and GEO1900 complexed with AKG 5E25. The PDB codes
for AF0933 holo enzyme 5MQZ and AF0933 complexed with
gabaculine 5MR0.
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